Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis
Open Access
- 1 February 1998
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 57 (2), 70-78
- https://doi.org/10.1136/ard.57.2.70
Abstract
No abstract availableThis publication has 89 references indexed in Scilit:
- SUSTAINED-RELEASE TRANSDERMAL GLYCERYL TRINITRATE PATCHES AS A TREATMENT FOR PRIMARY AND SECONDARY RAYNAUD'S PHENOMENONRheumatology, 1995
- Cutaneous Laser Doppler Flowmetry: Applications and FindingsMayo Clinic Proceedings, 1994
- Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenonThe Lancet, 1993
- Acute Effects and Mechanism of Action of Ketanserin in Patients with Primary Raynaudʼs PhenomenonJournal of Cardiovascular Pharmacology, 1990
- The effect of isradipine, a new calcium-channel antagonist, in patients with primary Raynaud's phenomenon: A single-blind dose-response studyCardiovascular Drugs and Therapy, 1989
- Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.Annals Of The Rheumatic Diseases, 1988
- An evaluation of finger systolic‐pressure response to local cooling in the diagnosis of primary Raynaud's phenomenonClinical Physiology and Functional Imaging, 1985
- Photoplethysmography of the Distal Pulp in the Assessment of the Vasospastic HandAngiology, 1985
- The effect of local cooling on digital systolic pressure in patients with Raynaud's syndromeBritish Journal of Surgery, 1982
- Long-term monitoring of the effects of thymoxamine hydrochloride tablets in the management of patients with Raynaud's diseaseCurrent Medical Research and Opinion, 1982